These results strongly suggested that, in patients with liver cancer, the cGAS-STING pathway may act a specific role for immune cell infiltration, including B cells, CD8+ T cells, CD4+ T cells, macrophages, neutrophils, and DCs. The gene discussed is STING1; the disease is liver cancer.